期刊文献+

^(18)F-FDG PET/CT在乳腺癌原发病灶诊断及分期的应用价值 被引量:6

原文传递
导出
出处 《中华临床医师杂志(电子版)》 CAS 2010年第10期136-140,共5页 Chinese Journal of Clinicians(Electronic Edition)
基金 教育部教育振兴行动计划特殊专项("九八五"工程:Ⅱ期)资助项目(985-2-056) 国家自然科学基金项目(30670583 30870729) 国家重点基础研究发展计划(973计划)资助项目(2006CB705705)
  • 相关文献

参考文献2

二级参考文献22

  • 1张保宁,邵志敏,乔新民,李波,姜军,杨名添,王水,宋三泰,张斌,杨红健.中国乳腺癌保乳治疗的前瞻性多中心研究[J].中华肿瘤杂志,2005,27(11):680-684. 被引量:247
  • 2杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 3BarrangerE, GrahekD,AntoineM, etal. Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early- stage breast cancer[J]. Ann Surg Oncol,2003,10(6):622-627.
  • 4Wahl R L, Siegel B A, Coleman R E, et al. PET Study Group:Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer:, a report of the staging breast cancer with PET Study Group[J]. J Clin Oncol, 2004,22(2):27
  • 5Cox C E, Salud C J, Cantor A, et al. Learning cnrves for breast cancer sentinel lymph node mapping based on surgical volume analysis[J]. J Am Coll Surg, 2001,193(6):593-600.
  • 6Zornoza G, Gareia-Velloso M J, Sola Let al. 18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast caneer[J]. Eur J Surg Oncol, 2004,30(1): 15 - 19.
  • 7Brady E W. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cance[J]. Breast J, 2002,8(2):97-100.
  • 8Donahue E J. Sentinel node imaging and biopsy in breast cancer patients[J]. Am J Surg, 2001,182(4):426-428.
  • 9HubnerKF,SmithGT,ThieJA, et al. The potential of F-18-FDG PET in breast cancer :Detection of primary lesion,axillary lymph node metastases,or distant metastases [J]. Clin Positron Imaging, 2000,3(5): 197- 205.
  • 10S Eva Singletary, Craig Allred, Pandora Ashley, et al. Revision of the American Joint Committee on cancer staging system for breast cancer[J]. J Clin Oncol,2002,20: 3628-3636.

共引文献13

同被引文献54

  • 1陈敬,陈正堂,邹岚,曹正怀.非小细胞肺癌患者外周血VEGF、CK19mRNA、CEA和TSGF联合检测的意义[J].重庆医学,2004,33(7):977-979. 被引量:15
  • 2李宝江,朱志华,王军业,侯景辉,赵进明,张蓬原,姚广裕,王曦,龙浩,杨名添,戎铁.Ki67、P53、VEGF和C-erbB-2在乳腺癌组织中表达的相关性研究及其临床意义[J].癌症,2004,23(10):1176-1179. 被引量:126
  • 3赵先文,江波,韩存芝,荆洁线.大肠癌患者血清肿瘤标志物含量测定与临床研究[J].中华肿瘤杂志,2005,27(5):286-288. 被引量:49
  • 4陈心,罗素兰,张本,长孙东亭.多肽固相合成的研究进展[J].生物技术,2006,16(1):81-83. 被引量:10
  • 5Zhuang H, Pourdehnad M, Lambright ES, et al. Dual time point lSF-FDG PET imaging for differentiating malignant from inflam- matory processes. J Nucl Med, 2001,42(9):1412-1417.
  • 6Mavi A, Urhan M, Yu JQ, et al. Dual time point ISF-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. J Nucl Med, 2006, 47 (9) : 1440- 1446.
  • 7Zytoon AA, Murakami K, E1-Kholy MR, et al. Breast cancer with low FDG uptake: Characterization by means of dual-time point FDG-PET/CT. Eur J Radiol, 2009,70(3) :530-538.
  • 8Zytoon AA, Murakami K, El-Kholy MR, et al. Dual time point FDG-PET/CT imaging--potential tool for diagnosis of breast cancer. Clin RadioI, 2008,63(11):1213-1227.
  • 9Imbriaco M, Caprio MG, Limite G, et al. Dual-time-point 18F- FDG PET/CT versus dynamic breast MRI of suspicious breast le- sions. AJR Am J Roentgenol, 2008,191(5) :1323-1330.
  • 10Caprio MG, Cangiano A, Imbriaco M, et al. Dual-time-point 18F FDG PET/CT in the diagnostic evaluation of suspicious breast lesions. Radiol Med, 2010,115(2):215-224.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部